| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
|
Free Radic Biol Med
|
2005
|
2.51
|
|
2
|
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
|
Free Radic Biol Med
|
2002
|
2.10
|
|
3
|
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
|
Neurobiol Dis
|
2006
|
2.04
|
|
4
|
Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes.
|
Am J Physiol Endocrinol Metab
|
2004
|
2.03
|
|
5
|
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.
|
J Neurochem
|
2002
|
1.73
|
|
6
|
Differential expression of proteins in renal cortex and medulla: a proteomic approach.
|
Kidney Int
|
2002
|
1.61
|
|
7
|
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.
|
Neurobiol Dis
|
2005
|
1.58
|
|
8
|
Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding.
|
Mol Cell Biol
|
2003
|
1.53
|
|
9
|
Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
|
Neurobiol Aging
|
2005
|
1.52
|
|
10
|
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis.
|
Neurobiol Aging
|
2005
|
1.50
|
|
11
|
AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.
|
Cancer Res
|
2007
|
1.48
|
|
12
|
AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin.
|
Mol Cancer Ther
|
2006
|
1.44
|
|
13
|
Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
|
Neurobiol Dis
|
2008
|
1.38
|
|
14
|
Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection.
|
J Clin Invest
|
2002
|
1.34
|
|
15
|
Proteomics analysis of the Alzheimer's disease hippocampal proteome.
|
J Alzheimers Dis
|
2007
|
1.32
|
|
16
|
Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease.
|
Mol Cell Proteomics
|
2005
|
1.25
|
|
17
|
An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach.
|
J Neurosci Res
|
2007
|
1.23
|
|
18
|
Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
|
Brain Res
|
2009
|
1.22
|
|
19
|
Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.
|
Neurobiol Aging
|
2006
|
1.17
|
|
20
|
Protein modification by acrolein: formation and stability of cysteine adducts.
|
Chem Res Toxicol
|
2009
|
1.11
|
|
21
|
Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis.
|
Neurobiol Aging
|
2005
|
1.10
|
|
22
|
Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease.
|
Neurobiol Aging
|
2005
|
1.09
|
|
23
|
Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis.
|
Proteomics Clin Appl
|
2009
|
1.08
|
|
24
|
Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells.
|
Invest Ophthalmol Vis Sci
|
2008
|
1.07
|
|
25
|
Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis.
|
J Am Soc Nephrol
|
2004
|
1.05
|
|
26
|
Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease.
|
Antioxid Redox Signal
|
2010
|
1.04
|
|
27
|
Identification of the p16-Arc subunit of the Arp 2/3 complex as a substrate of MAPK-activated protein kinase 2 by proteomic analysis.
|
J Biol Chem
|
2003
|
1.04
|
|
28
|
Hemoglobin expression and regulation in glaucoma: insights into retinal ganglion cell oxygenation.
|
Invest Ophthalmol Vis Sci
|
2009
|
1.03
|
|
29
|
Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
|
Free Radic Biol Med
|
2005
|
1.03
|
|
30
|
Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study.
|
J Cell Mol Med
|
2007
|
1.02
|
|
31
|
Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent.
|
Bioorg Med Chem Lett
|
2008
|
1.02
|
|
32
|
Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.
|
J Proteomics
|
2011
|
1.01
|
|
33
|
Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule.
|
J Cell Mol Med
|
2008
|
1.00
|
|
34
|
2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain.
|
Free Radic Biol Med
|
2011
|
1.00
|
|
35
|
Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts.
|
Biochem Biophys Res Commun
|
2005
|
0.98
|
|
36
|
2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2.
|
Mol Carcinog
|
2007
|
0.97
|
|
37
|
Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
|
J Proteome Res
|
2009
|
0.96
|
|
38
|
Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension.
|
J Biol Chem
|
2002
|
0.96
|
|
39
|
Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors.
|
J Biol Chem
|
2002
|
0.96
|
|
40
|
Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein.
|
Brain Res Mol Brain Res
|
2005
|
0.96
|
|
41
|
Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment.
|
J Alzheimers Dis
|
2006
|
0.95
|
|
42
|
Proteomic analysis of CA1 and CA3 regions of rat hippocampus and differential susceptibility to intermittent hypoxia.
|
J Neurochem
|
2002
|
0.95
|
|
43
|
Biochemical and mass spectrometric characterization of the human CB2 cannabinoid receptor expressed in Pichia pastoris--importance of correct processing of the N-terminus.
|
Protein Expr Purif
|
2007
|
0.94
|
|
44
|
Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations.
|
Mutat Res
|
2009
|
0.94
|
|
45
|
Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450.
|
Drug Metab Dispos
|
2004
|
0.94
|
|
46
|
Expression of CB2 cannabinoid receptor in Pichia pastoris.
|
Protein Expr Purif
|
2002
|
0.94
|
|
47
|
2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced DNA adduct formation and mutagenesis in DNA repair-deficient Chinese hamster ovary cells expressing human cytochrome P4501A1 and rapid or slow acetylator N-acetyltransferase 2.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.93
|
|
48
|
Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.
|
Neurobiol Dis
|
2010
|
0.93
|
|
49
|
Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells.
|
PLoS One
|
2012
|
0.92
|
|
50
|
Gamma-amino butyric acid type B receptors stimulate neutrophil chemotaxis during ischemia-reperfusion.
|
J Immunol
|
2005
|
0.92
|
|
51
|
Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress.
|
J Biol Chem
|
2005
|
0.92
|
|
52
|
High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver.
|
J Hepatol
|
2011
|
0.91
|
|
53
|
Fetal alcohol syndrome (FAS) in C57BL/6 mice detected through proteomics screening of the amniotic fluid.
|
Birth Defects Res A Clin Mol Teratol
|
2008
|
0.91
|
|
54
|
Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes.
|
Arch Biochem Biophys
|
2007
|
0.88
|
|
55
|
Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
|
J Alzheimers Dis
|
2011
|
0.88
|
|
56
|
Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice.
|
Free Radic Biol Med
|
2006
|
0.86
|
|
57
|
Oxidative stress in the aging murine olfactory bulb: redox proteomics and cellular localization.
|
J Neurosci Res
|
2007
|
0.86
|
|
58
|
METHODS FOR AROMATIC AND HETEROCYCLIC AMINE CARCINOGEN-DNA ADDUCT ANALYSIS BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.
|
Polycycl Aromat Compd
|
2008
|
0.85
|
|
59
|
Proteomic identification of a novel protein regulated in CA1 and CA3 hippocampal regions during intermittent hypoxia.
|
Respir Physiol Neurobiol
|
2003
|
0.84
|
|
60
|
Proteomic identification of nitrated brain proteins in traumatic brain-injured rats treated postinjury with gamma-glutamylcysteine ethyl ester: insights into the role of elevation of glutathione as a potential therapeutic strategy for traumatic brain injury.
|
J Neurosci Res
|
2009
|
0.84
|
|
61
|
Protective effect of D609 against amyloid-beta1-42-induced oxidative modification of neuronal proteins: redox proteomics study.
|
J Neurosci Res
|
2006
|
0.84
|
|
62
|
Nardilysin facilitates complex formation between mitochondrial malate dehydrogenase and citrate synthase.
|
Biochim Biophys Acta
|
2005
|
0.84
|
|
63
|
Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.
|
J Proteomics
|
2011
|
0.83
|
|
64
|
The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
|
J Neurosci Res
|
2010
|
0.82
|
|
65
|
Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx).
|
Mutat Res
|
2009
|
0.82
|
|
66
|
Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.
|
Cancer Lett
|
2011
|
0.81
|
|
67
|
Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
|
Drug Metab Dispos
|
2009
|
0.81
|
|
68
|
Sodium loading changes urinary protein excretion: a proteomic analysis.
|
Am J Physiol Renal Physiol
|
2003
|
0.80
|
|
69
|
Involvement of Stat3 in mouse brain development and sexual dimorphism: a proteomics approach.
|
Brain Res
|
2010
|
0.79
|
|
70
|
Proteomics and diabetic nephropathy.
|
Contrib Nephrol
|
2004
|
0.79
|
|
71
|
Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion.
|
J Neurochem
|
2012
|
0.79
|
|
72
|
3-O-phosphate ester conjugates of 17-β-O-{1-[2-carboxy-(2-hydroxy-4-methoxy-3-carboxamido)anilido]ethyl}1,3,5(10)-estratriene as novel bone-targeting agents.
|
Bioorg Med Chem Lett
|
2010
|
0.78
|
|
73
|
Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis?
|
Antioxid Redox Signal
|
2012
|
0.78
|
|
74
|
Structural features of the lysosomal hydrolase mannose 6-phosphate uncovering enzyme.
|
Glycoconj J
|
2005
|
0.78
|
|
75
|
Proteomic analysis of brain protein expression levels in NF-kappabeta p50 -/- homozygous knockout mice.
|
Brain Res
|
2008
|
0.77
|
|
76
|
Modest fructose beverage intake causes liver injury and fat accumulation in marginal copper deficient rats.
|
Obesity (Silver Spring)
|
2013
|
0.77
|
|
77
|
Defining mitogen-activated protein kinase pathways with mass spectrometry-based approaches.
|
Mass Spectrom Rev
|
2005
|
0.76
|